CONFERENCES

      International Drug Discovery Science and Technology

      IDDST is an annual conference that focuses on the latest developments in drug discovery research and technology, with topics ranging from target identification to clinical trials. The conference is aimed at drug discovery researchers, industry professionals, and other professionals involved in the study and application of drug discovery science and technology, and provides a forum for sharing knowledge and collaborating on new approaches to drug discovery.

      IDDST 2019

      Date

      Jul 24, 2019 - Jul 26, 2019

      Location

      Kyoto, Japan

      Bringing together 400 specialists from 36 countries and areas, IDDST 2019 includes 30 sessions covering a wide-range of topics in drug discovery research and provide a unique and ideal opportunity in life sciences of Drug Discovery, practical pharmaceutical sciences, clinical studies, industrial R&D and pipeline new drugs and translational medicine for industrial executives, academic professors, investors, marketing people, and governmental policymakers. 

      IDDST 2018

      Date

      Aug 15, 2018 - Aug 18, 2018

      Location

      Boston, USA

      Bringing together 300 specialists from 35 countries, this conference has for theme “Rethinking the Next Big Things in Pharma Innovations".

      See related posters

      See related presentations

      IDDST 2016

      Date

      Nov 16, 2016 - Nov 19, 2016

      Location

      Nanjing, China

      With 7 supporting concurrent conferences in Medicinal Chemistry, Drug Delivery, Cancer Immunotherapy, Regenerative Medicine and Stem Cells, Mircobes and Modern Chinese Medicine, as well as a variety of social events, IDDST 2016 brings over 2,000 participants from over 80 countries.

      IDDST 2010

      Date

      Oct 23, 2010 - Oct 26, 2010

      Location

      Beijing, China

      The 8th IDDST Annual Congress focuses on the accelerating preclinical and clinical drug discovery and drug therapy.

      See related presentations

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.